Project Details

Description

Summary Mitochondria are central intracellular organelles that mediate metabolism and ATP production. In order to maintain the function of mitochondria during stress, cardiomyocytes (CMs) have multiple layers of quality control mechanisms mediating mitochondrial fission/fusion, degradation and biogenesis. Mitophagy, a mitochondria-selective form of autophagy, is a major mechanism of degradation of damaged mitochondria and protects the heart against heart failure. In general, mitophagy is induced by the same molecular mechanisms commonly used by general autophagy, including ?autophagy-related? (Atg) molecules, and additional molecules, including Pink1/Parkin. However, increasing lines of evidence suggest that mitophagy is also induced independently of conventional autophagy. During the past funding cycle, we have shown that an unconventional form of mitophagy plays a more critical role in protecting the heart during ischemia than the conventional form of mitophagy. This unconventional form of mitophagy, called alternative mitophagy, utilizes molecular machinery distinct from that used by conventional mitophagy, namely the Ulk1-Rab9-Rip1-Drp1 protein complex. Currently, the functional significance and the molecular mechanisms of alternative mitophagy remain poorly understood. Our long-term goal is to demonstrate the functional significance of alternative mitophagy in the heart during chronic and more pathologically relevant conditions in vivo, elucidate the underlying molecular mechanisms, and eventually apply our knowledge to treat heart disease by stimulating alternative mitophagy. Interestingly, although conventional autophagy and mitophagy are activated in response to high fat diet (HFD) consumption in the mouse model of diabetic cardiomyopathy, their activation is transient and they protect the heart only during the early phase of HFD consumption. On the other hand, an unconventional form of mitophagy is activated in a more prolonged manner and appears to play an essential role in protecting the heart during the chronic phase of HFD consumption. We here hypothesize that alternative mitophagy is the predominant form of mitophagy in the heart during the chronic phase of HFD consumption and plays an essential role in protecting the heart against diabetic cardiomyopathy. Alternative mitophagy is activated through a TFE3-dependent transcriptional program and the direct association of a large protein complex, containing Drp1 and Drp1 interacting proteins, with mitochondria. We will test our hypothesis using unique indicators of mitophagy, genetically altered mouse models, morphological analyses, including immunogold analyses, lipidomics, transcriptome analyses, and ChIP-sequencing analyses. Our study will demonstrate a novel and targetable mitochondrial quality control mechanism during the chronic development of diabetic cardiomyopathy. Our study should lead to the development of novel interventions to maintain the quality of mitochondria in diabetic patients and alleviate their cardiac complications, including cardiac hypertrophy/dysfunction, lipotoxicity, and inflammation.
StatusFinished
Effective start/end date8/15/176/30/22

ASJC

  • Cardiology and Cardiovascular Medicine

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.